In this issue:
2nd-gen TKIs improve CML after imatinib failure
mAb216 in relapsed/refractory B-cell ALL
Laparoscopic splenectomy for ITP
Maintenance thalidomide in multiple myeloma
Predicting postremission survival in AML
Rituximab then CHOP in adult B-cell PTLD
Please login below to download this issue (PDF)